CytRx Investors Seek OK On $5.75M Stock Drop Settlement
An investor suing biopharmaceutical company CytRx Corp. over alleged misstatements that hurt its share price asked a California federal court on Friday for preliminary approval of a $5.75 million settlement....To view the full article, register now.
Already a subscriber? Click here to view full article